GLOW groups GHK-Cu, BPC-157 and a TB-500-listed component, bringing together separate lines of matrix-remodeling and tissue-signaling research.
Explore the research profileSubmit an unpaid laboratory order request for manual review. Availability and any pending amounts require confirmation.
Catalog quantities are not assay results.
Copper-peptide and tissue-signaling research blend
GLOW is a catalog blend name, not the name of a single molecule. Its listed components belong to different research families: a copper-binding tripeptide, a synthetic pentadecapeptide and a thymosin-related material. The currently available 70 mg formulation lists GHK-Cu 50 mg, BPC-157 10 mg and TB-500 10 mg. Those quantities describe the formulation listing, not measured recovery or purity.
This reference describes the published literature. Exact supplied form and chemical specifications require product-specific documentation. The studies are linked in Selected literature.
GHK-Cu experiments examine extracellular-matrix production and turnover. BPC-157 work explores cell migration and injury-associated signaling. Thymosin beta-4 research includes actin binding, but that mechanism cannot automatically be assigned to a short TB-500 fragment. The exact TB-500 sequence in this blend still requires confirmation. Overlap in research topics does not demonstrate compatible chemistry or a beneficial interaction between ingredients.
These links provide research context; they do not confirm the exact materials in this formulation.
Fibroblast experiments reported collagen-related responses to GHK-Cu. These are measurements of cells and their surrounding matrix, not evidence that the GLOW blend improves human skin. [1]
BPC-157 studies include tendon-derived cells and tissue preparations. Their migration and survival readouts concern the isolated experimental peptide, not this three-component formulation. [2]
Analytical work identifies short TB-500 as an acetylated seven-residue fragment. Full-length thymosin beta-4 has a different sequence and evidence base; the names cannot be used interchangeably. [3]
Study topics describe the cited models, not established benefits of this catalog material.
The selected evidence concerns individual components or identity-related materials. No study cited here tests the finished GLOW formulation or compares its catalog ratios. The research rationale is therefore a set of separate biological questions, rather than an established combined effect.
Copper complexation, component stability, sequence identity and analytical separation become important when interpreting a mixture. Component literature cannot establish the blend’s potency, shelf life, sterility or suitability. A final blend report would need to identify what was measured for each constituent, rather than treating one aggregate result as proof of every ingredient.
These papers concern individual components or related molecules. They do not validate this finished blend.
Foundational fibroblast collagen-synthesis experiment.
Rat tendon explants and fibroblasts; migration and stress-response endpoints.
Identification of Ac-LKKTETQ and reference synthesis; no therapeutic efficacy experiment.
Literature reviewed October 2026. This is a selected research overview, not an exhaustive systematic review. Published findings do not establish the identity, purity, sterility or suitability of any WYZ batch. For laboratory research only; not for human or veterinary use.
Final product specifications and product-specific storage instructions have not been supplied. Review the original documentation and your laboratory’s procedures before obtaining or using the material.
For qualified laboratory researchers. Not for human or veterinary use. Product information is not medical advice or a recommendation for personal use.
What to look for in a COAOther research blends in the collection.
Research Blends
Wolverine pairs BPC-157 with a TB-500-listed component, connecting preclinical tendon and gastrointestinal research with thymosin-related identity questions. The exact TB-500 sequence still requires confirmation.
BPC-157 10 mg + TB-500 10 mg
